- The administration’s latest salvo in the battle against high drug prices deals with Medicare Part B drugs, which are those usually given for serious diseases like cancer or arthritis and are administered in a doctor’s office or outpatient facility because they involve injections or infusions.
- The Medicare pricing for Plan B drugs often has been criticized for driving up costs. Medicare reimburses doctors for the costs they incur, plus 6 percent. Critics suggest that percentage encourages doctors to pay a high price for their drugs and that a flat administrative fee would be less inflationary.
- Despite a raft of statements in recent weeks by Republicans — including President Donald Trump — that they support protecting insurance coverage for people with preexisting medical problems, few GOP candidates have articulated any measures that would effectively do that.
- Guidance announced by the administration this week to allow states to seek waivers for their ACA insurance marketplaces would upend some of the “guardrails” designed to make sure that all plans provide a set group of benefits, including preexisting condition guarantees.
- Another proposed policy announced this week would allow employers to begin to decouple insurance from the job by giving workers tax-free money to buy policies on the ACA marketplaces.
- Share on X (Opens in new window) X
- Share on Facebook (Opens in new window) Facebook
- Share on LinkedIn (Opens in new window) LinkedIn
- Email a link to a friend (Opens in new window) Email
- Print (Opens in new window) Print
Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.